Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

Quality of life assumptions determine which cervical cancer screening strategies are cost-effective.

de Kok IMCM, Korfage IJ, van den Hout WB, Helmerhorst TJM, Habbema JDF, Essink-Bot ML, van Ballegooijen M.

Int J Cancer. 2018 Jun 1;142(11):2383-2393. doi: 10.1002/ijc.31265. Epub 2018 Feb 8.

2.

Effect of Cervical Cancer Screening Programs on Preterm Birth: A Decision and Cost-Effectiveness Analysis.

Kamphuis EI, Naber SK, Danhof NA, Habbema JDF, de Groot CJM, Mol BWJ.

Obstet Gynecol. 2017 Dec;130(6):1207-1217. doi: 10.1097/AOG.0000000000002366.

PMID:
29112652
3.

A revised prediction model for natural conception.

Bensdorp AJ, van der Steeg JW, Steures P, Habbema JDF, Hompes PGA, Bossuyt PMM, van der Veen F, Mol BWJ, Eijkemans MJC; CECERM study group.

Reprod Biomed Online. 2017 Jun;34(6):619-626. doi: 10.1016/j.rbmo.2017.03.014. Epub 2017 Mar 28.

PMID:
28434653
4.

Realizing a desired family size: when should couples start?

Habbema JD, Eijkemans MJ, Leridon H, te Velde ER.

Hum Reprod. 2015 Sep;30(9):2215-21. doi: 10.1093/humrep/dev148. Epub 2015 Jul 15.

5.

Models in the development of clinical practice guidelines.

Habbema JD, Wilt TJ, Etzioni R.

Ann Intern Med. 2015 Apr 7;162(7):530-1. doi: 10.7326/L15-5075-2. No abstract available.

PMID:
25845011
6.

Models in the development of clinical practice guidelines.

Habbema JD, Wilt TJ, Etzioni R, Nelson HD, Schechter CB, Lawrence WF, Melnikow J, Kuntz KM, Owens DK, Feuer EJ.

Ann Intern Med. 2014 Dec 2;161(11):812-8. doi: 10.7326/M14-0845.

PMID:
25437409
7.

Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.

van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG.

Ann Intern Med. 2014 Jun 3;160(11):750-9. doi: 10.7326/M13-2263.

8.

The influence of disease risk on the optimal time interval between screens for the early detection of cancer: a mathematical approach.

O'Mahony JF, van Rosmalen J, Mushkudiani NA, Goudsmit FW, Eijkemans MJ, Heijnsdijk EA, Steyerberg EW, Habbema JD.

Med Decis Making. 2015 Feb;35(2):183-95. doi: 10.1177/0272989X14528380. Epub 2014 Apr 16.

PMID:
24739535
9.

How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study.

Korfage IJ, Essink-Bot ML, Westenberg SM, Helmerhorst T, Habbema JD, van Ballegooijen M.

Gynecol Oncol. 2014 Jan;132(1):142-8. doi: 10.1016/j.ygyno.2013.11.001. Epub 2013 Nov 9.

PMID:
24219984
10.

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.

Goede SL, van Roon AH, Reijerink JC, van Vuuren AJ, Lansdorp-Vogelaar I, Habbema JD, Kuipers EJ, van Leerdam ME, van Ballegooijen M.

Gut. 2013 May;62(5):727-34. doi: 10.1136/gutjnl-2011-301917. Epub 2012 Apr 5.

11.

Postpartum physical activity after preeclampsia.

Hoedjes M, Berks D, Vogel I, Franx A, Oenema A, Duvekot JJ, Habbema JD, Steegers EA, Raat H.

Pregnancy Hypertens. 2012 Apr;2(2):143-51. doi: 10.1016/j.preghy.2012.01.003. Epub 2012 Jan 31.

PMID:
26105100
12.

Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening.

van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, Reijerink JC, Mannetje H', van der Togt AC, Habbema JD, van Leerdam ME, Kuipers EJ.

Gut. 2013 Mar;62(3):409-15. doi: 10.1136/gutjnl-2011-301583. Epub 2012 Mar 2.

PMID:
22387523
13.

Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients.

Hummelen R, Hemsworth J, Changalucha J, Butamanya NL, Hekmat S, Habbema JD, Reid G.

Nutrients. 2011 Oct;3(10):897-909. doi: 10.3390/nu3100897. Epub 2011 Oct 21.

14.

Fecal occult blood testing when colonoscopy capacity is limited.

Wilschut JA, Habbema JD, van Leerdam ME, Hol L, Lansdorp-Vogelaar I, Kuipers EJ, van Ballegooijen M.

J Natl Cancer Inst. 2011 Dec 7;103(23):1741-51. doi: 10.1093/jnci/djr385. Epub 2011 Nov 9.

PMID:
22076285
15.

The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.

Fischer EA, de Vlas SJ, Habbema JD, Richardus JH.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1330. doi: 10.1371/journal.pntd.0001330. Epub 2011 Sep 20.

16.

Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision.

Orroth KK, White RG, Freeman EE, Bakker R, Buvé A, Glynn JR, Habbema JD, Hayes RJ.

Sex Transm Infect. 2011 Dec;87(7):640-5. doi: 10.1136/sextrans-2011-050174. Epub 2011 Sep 16.

PMID:
21926115
17.

Symptoms of post-traumatic stress after preeclampsia.

Hoedjes M, Berks D, Vogel I, Franx A, Visser W, Duvekot JJ, Habbema JD, Steegers EA, Raat H.

J Psychosom Obstet Gynaecol. 2011 Sep;32(3):126-34. doi: 10.3109/0167482X.2011.599460.

PMID:
21824043
18.

Postpartum depression after mild and severe preeclampsia.

Hoedjes M, Berks D, Vogel I, Franx A, Bangma M, Darlington AS, Visser W, Duvekot JJ, Habbema JD, Steegers EA, Raat H.

J Womens Health (Larchmt). 2011 Oct;20(10):1535-42. doi: 10.1089/jwh.2010.2584. Epub 2011 Aug 4.

PMID:
21815820
19.

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.

Wilschut JA, Hol L, Dekker E, Jansen JB, Van Leerdam ME, Lansdorp-Vogelaar I, Kuipers EJ, Habbema JD, Van Ballegooijen M.

Gastroenterology. 2011 Nov;141(5):1648-55.e1. doi: 10.1053/j.gastro.2011.07.020. Epub 2011 Jul 22.

PMID:
21784045
20.

Clarifying differences in natural history between models of screening: the case of colorectal cancer.

van Ballegooijen M, Rutter CM, Knudsen AB, Zauber AG, Savarino JE, Lansdorp-Vogelaar I, Boer R, Feuer EJ, Habbema JD, Kuntz KM.

Med Decis Making. 2011 Jul-Aug;31(4):540-9. doi: 10.1177/0272989X11408915. Epub 2011 Jun 14.

Supplemental Content

Loading ...
Support Center